HomeLINCOLN • NSE
add
Lincoln Pharmaceuticals Ltd
Previous close
₹617.20
Day range
₹612.00 - ₹622.45
Year range
₹534.80 - ₹811.85
Market cap
12.34B INR
Avg Volume
31.65K
P/E ratio
12.83
Dividend yield
0.29%
Primary exchange
NSE
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 1.61B | 3.35% |
Operating expense | 637.66M | 18.98% |
Net income | 263.30M | -4.79% |
Net profit margin | 16.33 | -7.90% |
Earnings per share | — | — |
EBITDA | 283.79M | -8.84% |
Effective tax rate | 24.30% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.97B | 15.59% |
Total assets | 7.80B | 17.57% |
Total liabilities | 1.41B | 19.82% |
Total equity | 6.39B | — |
Shares outstanding | 20.02M | — |
Price to book | 1.93 | — |
Return on assets | — | — |
Return on capital | 10.19% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 263.30M | -4.79% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1979
Employees
1,687
